FIELD: medicine.
SUBSTANCE: invention relates to medicine, namely to ophthalmology, and is a method for evaluating the effectiveness of neuroretinoprotective treatment of primary open-angle glaucoma with the use of the drug Retinalamin, including the determination of the content of neuron-specific enolase (neuron specific enolase or NSE) in the tear fluid, according to the invention it is determined before and after the treatment and with a decrease in the NSE content of at least 20 % of the initial indicator, the result of neuroretin protection is evaluated as effective.
EFFECT: use of the invention improves the accuracy of diagnosis of POAG by obtaining reliable criteria for evaluating the effectiveness of neuroretin-protection.
1 cl, 2 ex
| Title | Year | Author | Number |
|---|---|---|---|
| METHOD FOR ASSESSING THE EFFICACY OF NEURORETINOPROTECTION OF PRIMARY OPEN-ANGLE GLAUCOMA ON BASIS OF DETERMINING RATIO OF NEURAL MARKERS | 2018 |
|
RU2681654C1 |
| METHOD OF ESTIMATING THE EFFICIENCY OF NEURORETIN PROTECTION OF PRIMARY OPEN-ANGLE GLAUCOMA BASED ON DETERMINATION OF THE NEUROTROPHIC FACTOR OF THE BRAIN | 2018 |
|
RU2681934C1 |
| METHOD FOR CORRECTION OF NEUROTROPHILIC CHANGES IN PATIENTS WITH PRIMARY OPEN-ANGLE GLAUCOMA AFTER CORONAVIRUS INFECTION | 2023 |
|
RU2814770C1 |
| METHOD OF TREATING ISCHEMIC TYPE OF PRIMARY OPEN-ANGLE GLAUCOMA IN INDIVIDUALS WITH NEAT SIGHT | 2010 |
|
RU2438670C1 |
| METHOD FOR DETERMINING THE INDICATIONS FOR THE INTRAVITREUM ADMINISTRATION OF THE BRAIN-DERIVED NEUROTROPHIC FACTOR FOR THE TREATMENT OF THE PRIMARY OPEN-ANGLE GLAUCOMA | 2018 |
|
RU2678095C1 |
| METHOD FOR DIAGNOSTICS OF INITIAL STAGE OF PRIMARY OPEN-ANGLE GLAUCOMA IN ELDERLY AND SENILE PATIENTS | 2020 |
|
RU2749476C1 |
| METHOD OF PREVENTION OF THE PROGRESSION OF PRIMARY OPEN-ANGLE GLAUCOMA | 2023 |
|
RU2799582C1 |
| METHOD OF EARLY DIAGNOSTICS OF PRIMARY OPEN-ANGLE GLAUCOMA | 2009 |
|
RU2392864C1 |
| METHOD OF DETERMINATION OF THE STAGE OF PRIMARY OPEN-TINED GLAUCOM | 2016 |
|
RU2616212C1 |
| METHOD OF TREATING INVOLUTIONAL EYE DISEASES | 2011 |
|
RU2565840C2 |
